Skip to main content
Signal8

Nguyen Alexander Hieu

SEC insider (Form 3/4/5 filer). CIK 0001850065. CLO and Head of Ops at Unity Biotechnology, Inc. (UBX). 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies Nguyen Alexander Hieu has filed insider reports for

  • Unity Biotechnology, Inc. (UBX): Officer, CLO and Head of Ops
Nguyen Alexander Hieu profile photo

Nguyen Alexander Hieu

CIK: 0001850065

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Unity Biotechnology, Inc. logo
UBX

Unity Biotechnology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Apr 2, 2025
    Sale
    Direct
    17.9K shares at avg. $1.03$18K
  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Mar 28, 2025
    Award
    Direct
    44K shares-
  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Mar 27, 2025
    Sale
    Direct
    2K shares at avg. $1.16$2K
  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Feb 4, 2025
    Sale
    Direct
    164 shares at avg. $2.23$365.72
  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Jan 22, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    150K shares-
  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Nov 4, 2024
    Sale
    Direct
    149 shares at avg. $1.29$192.21

1-6 of 6